Stryker Corporation (SYK) : Tukman Grossman Capital Management Inc reduced its stake in Stryker Corporation by 0.28% during the most recent quarter end. The investment management company now holds a total of 1,251,100 shares of Stryker Corporation which is valued at $138,759,501 after selling 3,500 shares in Stryker Corporation , the firm said in a disclosure report filed with the SEC on May 9, 2016.Stryker Corporation makes up approximately 8.04% of Tukman Grossman Capital Management Inc’s portfolio.
Other Hedge Funds, Including , Cottage Street Advisors reduced its stake in SYK by selling 443 shares or 2.85% in the most recent quarter. The Hedge Fund company now holds 15,087 shares of SYK which is valued at $1,673,299. Stryker Corporation makes up approx 1.48% of Cottage Street Advisors’s portfolio.Parkside Financial Bank Trust boosted its stake in SYK in the latest quarter, The investment management firm added 59 additional shares and now holds a total of 139 shares of Stryker Corporation which is valued at $15,458. Stryker Corporation makes up approx 0.01% of Parkside Financial Bank Trust’s portfolio.Alexandria Capital boosted its stake in SYK in the latest quarter, The investment management firm added 4 additional shares and now holds a total of 507 shares of Stryker Corporation which is valued at $55,268. Stryker Corporation makes up approx 0.01% of Alexandria Capital’s portfolio.Oppenheimer Co Inc reduced its stake in SYK by selling 551 shares or 1.5% in the most recent quarter. The Hedge Fund company now holds 36,140 shares of SYK which is valued at $3,939,621. Stryker Corporation makes up approx 0.12% of Oppenheimer Co Inc’s portfolio.
Stryker Corporation closed down -0.91 points or -0.81% at $110.91 with 10,50,700 shares getting traded on Friday. Post opening the session at $111.91, the shares hit an intraday low of $110.41 and an intraday high of $112.01 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.
Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Upgraded by Sterne Agee CRT to ” Buy” on Apr 27, 2016. Company shares were Reiterated by RBC Capital Mkts on Apr 26, 2016 to “Outperform”, Firm has raised the Price Target to $ 120 from a previous price target of $108 .Company shares were Downgraded by Robert W. Baird on Apr 13, 2016 to ” Neutral”, Firm has raised the Price Target to $ 116 from a previous price target of $111 .
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.